Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: PDUFA | Statement: [Prescription Drug User Fee Act of 1992, shortName, PDUFA]

Target entity: PDUFA
Context triple: [Prescription Drug User Fee Act of 1992, shortName, PDUFA]

• A. Food and Drug Administration Amendments Act of 2007
  The Food and Drug Administration Amendments Act of 2007 is a U.S. law that expanded the FDA’s authority over drug and device safety, clinical trials, and post-market surveillance, while enhancing transparency and user fee programs.
• B. Food and Drug Administration Safety and Innovation Act of 2012
  The Food and Drug Administration Safety and Innovation Act of 2012 is a U.S. federal law that reauthorized and expanded FDA user fee programs while enhancing the agency’s authority over drug and medical device safety, innovation, and supply chain oversight.
• C. Prescription Drug User Fee Act of 1992 chosen
  The Prescription Drug User Fee Act of 1992 is a U.S. law that authorizes the FDA to collect fees from pharmaceutical companies to fund and expedite the review of new drug applications.
• D. Food and Drug Administration Modernization Act of 1997
  The Food and Drug Administration Modernization Act of 1997 is a U.S. law that overhauled FDA regulatory procedures to speed the approval of drugs and medical devices while enhancing patient access to experimental therapies and modernizing agency operations.
• E. Leahy–Smith America Invents Act
  The Leahy–Smith America Invents Act is a 2011 U.S. patent reform law that overhauled the patent system, including shifting to a first-inventor-to-file regime and creating new post-grant review procedures.
• F. None of above.
• G. Unsure - the case is ambiguous/there is not enough information to decide.